Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Upgrade
Cemig upgraded to Overweight from Neutral at JPMorgan » 04:51
05/27/21
05/27
04:51
05/27/21
04:51
CIG

Cemig

$2.49 /

+0.01 (+0.40%)

JPMorgan analyst Fernando…

JPMorgan analyst Fernando Abdalla upgraded Cemig to Overweight from Neutral with a R$16 price target.

ShowHide Related Items >><<
CIG Cemig
$2.49 /

+0.01 (+0.40%)

01/13/21 HSBC
Cemig price target raised to R$17 from R$14 at HSBC
08/21/20 JPMorgan
Cemig upgraded to Neutral from Underweight at JPMorgan
08/02/20 Goldman Sachs
Copel downgraded to Neutral from Buy at Goldman Sachs
CIG Cemig
$2.49 /

+0.01 (+0.40%)

Over a month ago
Options
CEMIG options imply 8.3% move in share price post-earnings » 15:19
05/14/21
05/14
15:19
05/14/21
15:19
CIG

Cemig

$2.26 /

+0.07 (+3.20%)

Pre-earnings options…

Pre-earnings options volume in CEMIG is normal with calls leading puts 8:3. Implied volatility suggests the market is anticipating a move near 8.3%, or 19c, after results are released. Median move over the past eight quarters is 3.0%.

ShowHide Related Items >><<
CIG Cemig
$2.26 /

+0.07 (+3.20%)

01/13/21 HSBC
Cemig price target raised to R$17 from R$14 at HSBC
08/21/20 JPMorgan
Cemig upgraded to Neutral from Underweight at JPMorgan
08/02/20 Goldman Sachs
Copel downgraded to Neutral from Buy at Goldman Sachs
CIG Cemig
$2.26 /

+0.07 (+3.20%)

Options
CEMIG options imply 9.7% move in share price post-earnings » 15:19
03/26/21
03/26
15:19
03/26/21
15:19
CIG

Cemig

$2.12 /

-0.03 (-1.40%)

Pre-earnings options…

Pre-earnings options volume in CEMIG is normal with puts leading calls 8:3. Implied volatility suggests the market is anticipating a move near 9.7%, or 21c, after results are released. Median move over the past eight quarters is 3.6%.

ShowHide Related Items >><<
CIG Cemig
$2.12 /

-0.03 (-1.40%)

01/13/21 HSBC
Cemig price target raised to R$17 from R$14 at HSBC
08/21/20 JPMorgan
Cemig upgraded to Neutral from Underweight at JPMorgan
08/02/20 Goldman Sachs
Copel downgraded to Neutral from Buy at Goldman Sachs
Over a quarter ago
Recommendations
Cemig price target raised to R$17 from R$14 at HSBC » 12:46
01/13/21
01/13
12:46
01/13/21
12:46
CIG

Cemig

$2.80 /

-0.005 (-0.18%)

HSBC analyst Lilyanna…

HSBC analyst Lilyanna Yang raised the firm's price target on Cemig to R$17 from R$14 and keeps a Buy rating on the shares. The company's acquisition outlook has improved following the sale of its 23% stake in Rio de Janeiro-based Light, Yang tells investors in a research note. The sale should generate tax credits from capital losses, which could be used this year if Cemig is able to divest other assets at a gain, says the analyst. She views the company as a "restructuring story with robust dividend income."

ShowHide Related Items >><<
CIG Cemig
$2.80 /

-0.005 (-0.18%)

08/21/20 JPMorgan
Cemig upgraded to Neutral from Underweight at JPMorgan
08/02/20 Goldman Sachs
Copel downgraded to Neutral from Buy at Goldman Sachs
CIG Cemig
$2.80 /

-0.005 (-0.18%)

Upgrade
Cemig upgraded to Neutral from Underweight at JPMorgan » 05:02
08/21/20
08/21
05:02
08/21/20
05:02
CIG

Cemig

$1.94 /

-0.01 (-0.51%)

JPMorgan analyst Fernando…

JPMorgan analyst Fernando Abdalla upgraded Cemig to Neutral from Underweight with a R$12 price target.

ShowHide Related Items >><<
CIG Cemig
$1.94 /

-0.01 (-0.51%)

08/02/20 Goldman Sachs
Copel downgraded to Neutral from Buy at Goldman Sachs
11/14/19 Goldman Sachs
Cemig initiated with a Buy at Goldman Sachs
CIG Cemig
$1.94 /

-0.01 (-0.51%)

Options
CEMIG options imply 29.4% move in share price post-earnings » 15:19
08/14/20
08/14
15:19
08/14/20
15:19
CIG

Cemig

$1.95 /

-0.015 (-0.76%)

Pre-earnings options…

Pre-earnings options volume in CEMIG is normal with calls leading puts 6:1. Implied volatility suggests the market is anticipating a move near 29.4%, or 57c, after results are released. Median move over the past eight quarters is 2.4%.

ShowHide Related Items >><<
CIG Cemig
$1.95 /

-0.015 (-0.76%)

08/02/20 Goldman Sachs
Copel downgraded to Neutral from Buy at Goldman Sachs
11/14/19 Goldman Sachs
Cemig initiated with a Buy at Goldman Sachs
CIG Cemig
$1.95 /

-0.015 (-0.76%)

Options
Largest borrow rate increases among liquid names » 08:45
08/14/20
08/14
08:45
08/14/20
08:45
FTAI

Fortress Transportation

$16.67 /

-0.02 (-0.12%)

, CIG

Cemig

$1.97 /

+0.0996 (+5.34%)

, LPCN

Lipocine

$2.08 /

-0.005 (-0.24%)

, BHP

BHP Group

$57.03 /

-0.45 (-0.78%)

, ADMP

Adamis Pharmaceuticals

$1.01 /

+0.0403 (+4.16%)

, XERS

Xeris Pharmaceuticals

$3.65 /

+0.44 (+13.71%)

, AUPH

Aurinia Pharmaceuticals

$14.15 /

-0.05 (-0.35%)

, CEMI

Chembio Diagnostics

$5.10 /

-0.33 (-6.08%)

, NRG

NRG Energy

$35.31 /

+0.025 (+0.07%)

, EMAN

eMagin

$1.80 /

+0.42 (+30.43%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: Fortress Transportation (FTAI) 22.60% +4.69, CEMIG (CIG) 14.19% +3.09, Lipocine (LPCN) 14.68% +1.12, BHP Billiton (BHP) 1.32% +1.00, Adamis Pharmaceuticals (ADMP) 74.73% +0.68, Xeris Pharmaceuticals (XERS) 6.04% +0.40, Aurinia Pharmaceuticals (AUPH) 1.52% +0.30, Chembio Diagnostics (CEMI) 23.09% +0.15, NRG Energy (NRG) 0.40% +0.15, and eMagin (EMAN) 24.15% +0.14.

ShowHide Related Items >><<
XERS Xeris Pharmaceuticals
$3.65 /

+0.44 (+13.71%)

NRG NRG Energy
$35.31 /

+0.025 (+0.07%)

LPCN Lipocine
$2.08 /

-0.005 (-0.24%)

FTAI Fortress Transportation
$16.67 /

-0.02 (-0.12%)

EMAN eMagin
$1.80 /

+0.42 (+30.43%)

CEMI Chembio Diagnostics
$5.10 /

-0.33 (-6.08%)

BHP BHP Group
$57.03 /

-0.45 (-0.78%)

AUPH Aurinia Pharmaceuticals
$14.15 /

-0.05 (-0.35%)

ADMP Adamis Pharmaceuticals
$1.01 /

+0.0403 (+4.16%)

FTAI Fortress Transportation
$16.67 /

-0.02 (-0.12%)

07/17/20 Benchmark
Fortress Transportation initiated with a Buy at Benchmark
12/02/19 BTIG
Fortress Transportation initiated with a Buy at BTIG
12/02/19 BTIG
Fortress Transportation initiated with a Buy at BTIG
11/26/19
Fly Intel: Top five analyst initiations
CIG Cemig
$1.97 /

+0.0996 (+5.34%)

08/02/20 Goldman Sachs
Copel downgraded to Neutral from Buy at Goldman Sachs
11/14/19 Goldman Sachs
Cemig initiated with a Buy at Goldman Sachs
LPCN Lipocine
$2.08 /

-0.005 (-0.24%)

05/27/20 H.C. Wainwright
Lipocine price target raised to $3 from $2 at H.C. Wainwright
11/11/19 H.C. Wainwright
Lipocine price target lowered to $2 from $5 at H.C. Wainwright
11/11/19 Ladenburg
Lipocine downgraded to Neutral from Buy at Ladenburg
BHP BHP Group
$57.03 /

-0.45 (-0.78%)

07/24/20 RBC Capital
BHP Group price target lowered to 1,900 GBp from 1,950 GBp at RBC Capital
07/22/20 JPMorgan
BHP Group price target lowered to 1,870 GBp from 1,950 GBp at JPMorgan
07/21/20 Citi
BHP Group downgraded to Neutral from Buy at Citi
07/15/20 Goldman Sachs
Rio Tinto assumed with a Neutral at Goldman Sachs
ADMP Adamis Pharmaceuticals
$1.01 /

+0.0403 (+4.16%)

05/13/20 Maxim
Adamis Pharmaceuticals upgraded to Buy from Hold at Maxim
05/13/20 Maxim
Adamis Pharmaceuticals upgraded to Buy from Hold at Maxim
02/27/20 Dawson James
Dawson James downgrades Adamis to Neutral after 'worrisome' financing
02/27/20 Dawson James
Adamis Pharmaceuticals downgraded to Neutral from Buy at Dawson James
XERS Xeris Pharmaceuticals
$3.65 /

+0.44 (+13.71%)

04/23/20 Mizuho
Xeris Pharmaceuticals price target lowered to $14 from $18 at Mizuho
02/20/20 Mizuho
Xeris Pharmaceuticals price target lowered to $18 from $22 at Mizuho
02/18/20
Fly Intel: Top five analyst initiations
02/18/20 Piper Sandler
Xeris Pharmaceuticals initiated with an Overweight at Piper Sandler
AUPH Aurinia Pharmaceuticals
$14.15 /

-0.05 (-0.35%)

08/12/20 H.C. Wainwright
H.C. Wainwright ups Aurinia target to $34, sees voclosporin LN approval by PDUFA
07/22/20 H.C. Wainwright
H.C. Wainwright 'highly confident' in approval of Aurinia's voclosporin
06/16/20 BTIG
Aurinia Pharmaceuticals initiated with a Buy at BTIG
05/05/20 Cowen
Aurinia Pharmaceuticals initiated with an Outperform at Cowen
CEMI Chembio Diagnostics
$5.10 /

-0.33 (-6.08%)

06/17/20
Fly Intel: Top five analyst downgrades
06/17/20 Craig-Hallum
Chembio Diagnostics downgraded to Hold from Buy at Craig-Hallum
06/17/20 Colliers
Chembio Diagnostics downgraded to Neutral from Buy at Colliers
06/17/20 Canaccord
Chembio Diagnostics downgraded to Hold at Canaccord
NRG NRG Energy
$35.31 /

+0.025 (+0.07%)

05/20/20 Seaport Global
Seaport Global starts power and competitive retail sector with positive outlook
05/20/20 Seaport Global
NRG Energy initiated with a Buy at Seaport Global
04/02/20 Citi
NRG Energy price target lowered to $34 from $49 at Citi
03/03/20 Vertical Research
NRG Energy upgraded to Buy from Hold at Vertical Research
EMAN eMagin
$1.80 /

+0.42 (+30.43%)

XERS Xeris Pharmaceuticals
$3.65 /

+0.44 (+13.71%)

NRG NRG Energy
$35.31 /

+0.025 (+0.07%)

LPCN Lipocine
$2.08 /

-0.005 (-0.24%)

FTAI Fortress Transportation
$16.67 /

-0.02 (-0.12%)

CEMI Chembio Diagnostics
$5.10 /

-0.33 (-6.08%)

AUPH Aurinia Pharmaceuticals
$14.15 /

-0.05 (-0.35%)

ADMP Adamis Pharmaceuticals
$1.01 /

+0.0403 (+4.16%)

  • 23
    Jul
  • 26
    Jun
  • 07
    May
  • 12
    Feb
  • 10
    Dec
  • 14
    Nov
BHP BHP Group
$57.03 /

-0.45 (-0.78%)

XERS Xeris Pharmaceuticals
$3.65 /

+0.44 (+13.71%)

EMAN eMagin
$1.80 /

+0.42 (+30.43%)

CEMI Chembio Diagnostics
$5.10 /

-0.33 (-6.08%)

AUPH Aurinia Pharmaceuticals
$14.15 /

-0.05 (-0.35%)

XERS Xeris Pharmaceuticals
$3.65 /

+0.44 (+13.71%)

NRG NRG Energy
$35.31 /

+0.025 (+0.07%)

LPCN Lipocine
$2.08 /

-0.005 (-0.24%)

FTAI Fortress Transportation
$16.67 /

-0.02 (-0.12%)

EMAN eMagin
$1.80 /

+0.42 (+30.43%)

CIG Cemig
$1.97 /

+0.0996 (+5.34%)

CEMI Chembio Diagnostics
$5.10 /

-0.33 (-6.08%)

BHP BHP Group
$57.03 /

-0.45 (-0.78%)

AUPH Aurinia Pharmaceuticals
$14.15 /

-0.05 (-0.35%)

ADMP Adamis Pharmaceuticals
$1.01 /

+0.0403 (+4.16%)

Options
Largest borrow rate increases among liquid names » 08:45
08/13/20
08/13
08:45
08/13/20
08:45
KODK

Eastman Kodak

$9.71 /

-0.295 (-2.95%)

, CODX

Co-Diagnostics

$19.63 /

-3.61 (-15.53%)

, CEMI

Chembio Diagnostics

$5.43 /

+0.07 (+1.31%)

, TLRY

Tilray

$6.90 /

-0.02 (-0.29%)

, NAK

Northern Dynasty

$1.50 /

+0.015 (+1.01%)

, HLF

Herbalife Nutrition

$48.14 /

-0.94 (-1.92%)

, EMAN

eMagin

$1.38 /

-0.06 (-4.17%)

, LX

LexinFintech

$8.98 /

+0.355 (+4.12%)

, CIG

Cemig

$1.99 /

-0.0673 (-3.27%)

, SHLL

Tortoise Acquisition

$19.93 /

-0.06 (-0.30%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: Kodak (KODK) 25.06% +0.84, Co-Diagnostics (CODX) 18.25% +0.69, Chembio Diagnostics (CEMI) 15.43% +0.31, Tilray (TLRY) 49.13% +0.31, Northern Dynasty (NAK) 24.09% +0.27, Herbalife (HLF) 0.74% +0.24, eMagin (EMAN) 23.21% +0.20, LexinFintech (LX) 0.53% +0.20, CEMIG (CIG) 26.78% +0.18, and Tortoise Acquisition Corp (SHLL) 19.98% +0.18.

ShowHide Related Items >><<
TLRY Tilray
$6.90 /

-0.02 (-0.29%)

SHLL Tortoise Acquisition
$19.93 /

-0.06 (-0.30%)

NAK Northern Dynasty
$1.50 /

+0.015 (+1.01%)

LX LexinFintech
$8.98 /

+0.355 (+4.12%)

KODK Eastman Kodak
$9.71 /

-0.295 (-2.95%)

HLF Herbalife Nutrition
$48.14 /

-0.94 (-1.92%)

EMAN eMagin
$1.38 /

-0.06 (-4.17%)

CODX Co-Diagnostics
$19.63 /

-3.61 (-15.53%)

CEMI Chembio Diagnostics
$5.43 /

+0.07 (+1.31%)

KODK Eastman Kodak
$9.71 /

-0.295 (-2.95%)

CODX Co-Diagnostics
$19.63 /

-3.61 (-15.53%)

05/20/20 Maxim
Co-Diagnostics upgraded to Buy from Hold at Maxim
05/20/20 Maxim
Co-Diagnostics upgraded to Buy from Hold at Maxim
05/18/20 H.C. Wainwright
Co-Diagnostics price target raised to $35 from $20 at H.C. Wainwright
03/09/20 H.C. Wainwright
Co-Diagnostics price target raised to $20 from $4 at H.C. Wainwright
CEMI Chembio Diagnostics
$5.43 /

+0.07 (+1.31%)

06/17/20
Fly Intel: Top five analyst downgrades
06/17/20 Craig-Hallum
Chembio Diagnostics downgraded to Hold from Buy at Craig-Hallum
06/17/20 Colliers
Chembio Diagnostics downgraded to Neutral from Buy at Colliers
06/17/20 Canaccord
Chembio Diagnostics downgraded to Hold at Canaccord
TLRY Tilray
$6.90 /

-0.02 (-0.29%)

05/27/20 Roth Capital
Roth Capital sees Tilray operational moves as 'positive'
05/19/20 MKM Partners
Tilray price target raised to $8 from $5 at MKM Partners
05/12/20 Alliance Global Partners
Tilray price target lowered to $9 from $15 at Alliance Global Partners
05/12/20 Stifel
Tilray price target raised to $6.50 from $5.50 at Stifel
NAK Northern Dynasty
$1.50 /

+0.015 (+1.01%)

07/28/20 BMO Capital
Northern Dynasty price target raised to C$3.50 from C$1.50 at BMO Capital
06/29/20 TD Securities
Northern Dynasty price target raised to C$2.25 from C$1.30 at TD Securities
05/14/20 TD Securities
Northern Dynasty price target raised to C$1.30 from C$0.75 at TD Securities
HLF Herbalife Nutrition
$48.14 /

-0.94 (-1.92%)

06/22/20 Citi
Citi boosts Herbalife target to $63, opens '90 Day Catalyst Watch'
05/08/20 Jefferies
Herbalife Nutrition price target raised to $45 from $40 at Jefferies
05/08/20 Citi
Herbalife Nutrition price target raised to $56 from $49 at Citi
12/04/19 Citi
Herbalife Nutrition assumed with a Buy at Citi
EMAN eMagin
$1.38 /

-0.06 (-4.17%)

08/14/19
eMagin downgraded to Hold at Craig-Hallum
08/13/19 Craig-Hallum
eMagin downgraded to Hold from Buy at Craig-Hallum
LX LexinFintech
$8.98 /

+0.355 (+4.12%)

06/16/20 China Renaissance
China Renaissance ups LexinFintech to Buy, raises Fintech sector to Overweight
06/15/20 China Renaissance
LexinFintech upgraded to Buy from Hold at China Renaissance
06/09/20 Citi
LexinFintech upgraded to Buy following pullback at Citi
06/09/20 Citi
LexinFintech upgraded to Buy from Neutral at Citi
CIG Cemig
$1.99 /

-0.0673 (-3.27%)

08/02/20 Goldman Sachs
Copel downgraded to Neutral from Buy at Goldman Sachs
11/14/19 Goldman Sachs
Cemig initiated with a Buy at Goldman Sachs
SHLL Tortoise Acquisition
$19.93 /

-0.06 (-0.30%)

TLRY Tilray
$6.90 /

-0.02 (-0.29%)

KODK Eastman Kodak
$9.71 /

-0.295 (-2.95%)

HLF Herbalife Nutrition
$48.14 /

-0.94 (-1.92%)

CODX Co-Diagnostics
$19.63 /

-3.61 (-15.53%)

CEMI Chembio Diagnostics
$5.43 /

+0.07 (+1.31%)

  • 11
    May
  • 07
    May
TLRY Tilray
$6.90 /

-0.02 (-0.29%)

KODK Eastman Kodak
$9.71 /

-0.295 (-2.95%)

CODX Co-Diagnostics
$19.63 /

-3.61 (-15.53%)

TLRY Tilray
$6.90 /

-0.02 (-0.29%)

SHLL Tortoise Acquisition
$19.93 /

-0.06 (-0.30%)

KODK Eastman Kodak
$9.71 /

-0.295 (-2.95%)

HLF Herbalife Nutrition
$48.14 /

-0.94 (-1.92%)

EMAN eMagin
$1.38 /

-0.06 (-4.17%)

CODX Co-Diagnostics
$19.63 /

-3.61 (-15.53%)

CEMI Chembio Diagnostics
$5.43 /

+0.07 (+1.31%)

TLRY Tilray
$6.90 /

-0.02 (-0.29%)

SHLL Tortoise Acquisition
$19.93 /

-0.06 (-0.30%)

NAK Northern Dynasty
$1.50 /

+0.015 (+1.01%)

KODK Eastman Kodak
$9.71 /

-0.295 (-2.95%)

HLF Herbalife Nutrition
$48.14 /

-0.94 (-1.92%)

EMAN eMagin
$1.38 /

-0.06 (-4.17%)

CODX Co-Diagnostics
$19.63 /

-3.61 (-15.53%)

CEMI Chembio Diagnostics
$5.43 /

+0.07 (+1.31%)

Downgrade
Copel downgraded to Neutral from Buy at Goldman Sachs » 21:20
08/02/20
08/02
21:20
08/02/20
21:20
ELP

Copel

$12.55 /

-0.36 (-2.79%)

, CIG

Cemig

$2.33 /

-0.1 (-4.12%)

Goldman Sachs analyst…

Goldman Sachs analyst Pedro Manfredini downgraded Copel (ELP) to Neutral from Buy with a R$66 price target. The analyst cites valuation for the downgrade. Manfredini now sees Copel as more expensive than comparable peers such as Cemig (CIG), a stock that remains Buy-rated.

ShowHide Related Items >><<
ELP Copel
$12.55 /

-0.36 (-2.79%)

ELP Copel
$12.55 /

-0.36 (-2.79%)

11/14/19 Goldman Sachs
Copel initiated with a Buy at Goldman Sachs
08/26/19
Fly Intel: Top five analyst upgrades
08/26/19 JPMorgan
Copel upgraded to Overweight from Neutral at JPMorgan
CIG Cemig
$2.33 /

-0.1 (-4.12%)

11/14/19 Goldman Sachs
Cemig initiated with a Buy at Goldman Sachs

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.